Streeterville Capital LLC 13D and 13G filings for China SXT Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-03-29 2:19 pm Purchase | 2023-03-29 | 13G | China SXT Pharmaceuticals, Inc. SXTC | Streeterville Capital LLC | 41,743 9.990% | 41,743 (New Position) | Filing |
| 2023-03-29 1:48 pm Sale | 2023-03-29 | 13G | China SXT Pharmaceuticals, Inc. SXTC | Streeterville Capital LLC | 0 0.000% | -8,117 (Position Closed) | Filing |
| 2022-08-25 3:57 pm Purchase | 2022-08-25 | 13G | China SXT Pharmaceuticals, Inc. SXTC | Streeterville Capital LLC | 8,117 9.990% | 8,117 (New Position) | Filing |